Quarterly report · Q2

Period2023-12-01 → 2024-05-31
Filed2024-07-10
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥4.2bn2023-12-01 → 2024-05-31Cons.Net sales
Revenue¥8.6bn2022-12-01 → 2023-11-30Cons.Net sales (5-year summary)
Revenue¥4.2bn2022-12-01 → 2023-05-31Cons.Net sales
Operating income¥202m2023-12-01 → 2024-05-31Cons.Operating income
Operating income¥156m2022-12-01 → 2023-05-31Cons.Operating income
Ordinary income¥212m2023-12-01 → 2024-05-31Cons.Ordinary income
Ordinary income¥345m2022-12-01 → 2023-11-30Cons.Ordinary income loss (5-year summary)
Ordinary income¥156m2022-12-01 → 2023-05-31Cons.Ordinary income
Profit before tax¥252m2023-12-01 → 2024-05-31Cons.Income before income taxes
Profit before tax¥155m2022-12-01 → 2023-05-31Cons.Income before income taxes
Net income (owners)¥193m2023-12-01 → 2024-05-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥256m2022-12-01 → 2023-11-30Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥121m2022-12-01 → 2023-05-31Cons.Profit loss attributable to owners of parent
Net income¥193m2023-12-01 → 2024-05-31Cons.Profit loss
Net income¥121m2022-12-01 → 2023-05-31Cons.Profit loss
Total assets¥8.0bnat 2024-05-31Cons.Assets
Total assets¥8.3bnat 2023-11-30Cons.Assets
Total assets¥8.0bnat 2023-05-31Cons.Total assets (5-year summary)
Total liabilities¥5.3bnat 2024-05-31Cons.Liabilities
Total liabilities¥5.7bnat 2023-11-30Cons.Liabilities
Net assets / equity¥2.7bnat 2024-05-31Cons.Net assets
Net assets / equity¥2.6bnat 2023-11-30Cons.Net assets
Net assets / equity¥2.5bnat 2023-05-31Cons.Net assets (5-year summary)
Cash and deposits¥947mat 2024-05-31Cons.Cash and deposits
Cash and deposits¥1.0bnat 2023-11-30Cons.Cash and deposits
Cash & equivalents¥947mat 2024-05-31Cons.Cash and cash equivalents
Cash & equivalents¥1.0bnat 2023-11-30Cons.Cash and cash equivalents
Cash & equivalents¥999mat 2023-05-31Cons.Cash and cash equivalents
Cash & equivalents¥911mat 2022-11-30dCons.Cash and cash equivalents
Operating cash flow¥90m2023-12-01 → 2024-05-31Cons.Net cash provided by used in operating activities
Operating cash flow¥470m2022-12-01 → 2023-11-30Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥223m2022-12-01 → 2023-05-31Cons.Net cash provided by used in operating activities
Investing cash flow−¥96m2023-12-01 → 2024-05-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥370m2022-12-01 → 2023-11-30Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥217m2022-12-01 → 2023-05-31Cons.Net cash provided by used in investment activities
Financing cash flow−¥101m2023-12-01 → 2024-05-31Cons.Net cash provided by used in financing activities
Financing cash flow¥21m2022-12-01 → 2023-11-30Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow¥80m2022-12-01 → 2023-05-31Cons.Net cash provided by used in financing activities
EPS (basic)¥158.382023-12-01 → 2024-05-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥117.592024-03-01 → 2024-05-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥209.882022-12-01 → 2023-11-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥99.172022-12-01 → 2023-05-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥65.392023-03-01 → 2023-05-31dCons.Basic earnings loss per share (5-year summary)
Equity ratio34.2%at 2024-05-31Cons.Equity to asset ratio (5-year summary)
Equity ratio31.6%at 2023-11-30Cons.Equity to asset ratio (5-year summary)
Equity ratio31.1%at 2023-05-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 18
SegmentItemPeriodValue
jpcrp040300-q2r_E01006-000Pharmaceutical Productsreportable segmentrevenue2023-12-01 → 2024-05-31¥4.2bn
jpcrp040300-q2r_E01006-000Pharmaceutical Productsreportable segmentrevenue external2023-12-01 → 2024-05-31¥4.2bn
jpcrp040300-q2r_E01006-000Pharmaceutical Productsreportable segmentsegment profit2023-12-01 → 2024-05-31¥187m
jpcrp040300-q2r_E01006-000Real Estate Leasingreportable segmentrevenue2023-12-01 → 2024-05-31¥19m
jpcrp040300-q2r_E01006-000Real Estate Leasingreportable segmentrevenue external2023-12-01 → 2024-05-31¥19m
jpcrp040300-q2r_E01006-000Real Estate Leasingreportable segmentsegment profit2023-12-01 → 2024-05-31¥15m
Total Of Reportable Segments And Otherssegment totalrevenue2023-12-01 → 2024-05-31¥4.2bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-12-01 → 2024-05-31¥4.2bn
Total Of Reportable Segments And Otherssegment totalsegment profit2023-12-01 → 2024-05-31¥202m
jpcrp040300-q2r_E01006-000Pharmaceutical Productsreportable segmentrevenue2022-12-01 → 2023-05-31¥4.2bn
jpcrp040300-q2r_E01006-000Pharmaceutical Productsreportable segmentrevenue external2022-12-01 → 2023-05-31¥4.2bn
jpcrp040300-q2r_E01006-000Pharmaceutical Productsreportable segmentsegment profit2022-12-01 → 2023-05-31¥141m
jpcrp040300-q2r_E01006-000Real Estate Leasingreportable segmentrevenue2022-12-01 → 2023-05-31¥19m
jpcrp040300-q2r_E01006-000Real Estate Leasingreportable segmentrevenue external2022-12-01 → 2023-05-31¥19m
jpcrp040300-q2r_E01006-000Real Estate Leasingreportable segmentsegment profit2022-12-01 → 2023-05-31¥15m
Total Of Reportable Segments And Otherssegment totalrevenue2022-12-01 → 2023-05-31¥4.2bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-12-01 → 2023-05-31¥4.2bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-12-01 → 2023-05-31¥156m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 480
ItemContextValueUnit
Non operating incomePrior1YTDDuration8810000JPY
Non operating incomeCurrentYTDDuration19275000JPY
Interest expenses noePrior1YTDDuration8868000JPY
Interest expenses noeCurrentYTDDuration9474000JPY
Other noePrior1YTDDuration36000JPY
Other noeCurrentYTDDuration333000JPY
Non operating expensesPrior1YTDDuration8904000JPY
Non operating expensesCurrentYTDDuration9808000JPY
Ordinary incomePrior1YTDDuration156261000JPY
Ordinary incomeCurrentYTDDuration211885000JPY
Gain on sales of investment securities eiPrior1YTDDuration-JPY
Gain on sales of investment securities eiCurrentYTDDuration42660000JPY
Extraordinary incomePrior1YTDDuration-JPY
Extraordinary incomeCurrentYTDDuration42660000JPY
Loss on retirement of noncurrent assets elPrior1YTDDuration1064000JPY
Loss on retirement of noncurrent assets elCurrentYTDDuration2146000JPY
Extraordinary lossPrior1YTDDuration1064000JPY
Extraordinary lossCurrentYTDDuration2146000JPY
Income before income taxesPrior1YTDDuration155197000JPY
Income before income taxesCurrentYTDDuration252399000JPY
Income taxes currentPrior1YTDDuration26666000JPY
Income taxes currentCurrentYTDDuration40715000JPY
Income taxes deferredPrior1YTDDuration7797000JPY
Income taxes deferredCurrentYTDDuration18857000JPY
Income taxesPrior1YTDDuration34464000JPY
Income taxesCurrentYTDDuration59572000JPY
Profit lossPrior1YTDDuration120732000JPY
Profit lossCurrentYTDDuration192827000JPY
Profit loss attributable to non controlling interestsPrior1YTDDuration-JPY
Profit loss attributable to non controlling interestsCurrentYTDDuration-JPY
Profit loss attributable to owners of parentPrior1YTDDuration120732000JPY
Profit loss attributable to owners of parentCurrentYTDDuration192827000JPY
Profit lossPrior1YTDDuration120732000JPY
Profit lossCurrentYTDDuration192827000JPY
Valuation difference on available for sale securities net of tax ociPrior1YTDDuration6107000JPY
Valuation difference on available for sale securities net of tax ociCurrentYTDDuration-30909000JPY
Foreign currency translation adjustment net of tax ociPrior1YTDDuration3090000JPY
Foreign currency translation adjustment net of tax ociCurrentYTDDuration10161000JPY
Other comprehensive incomePrior1YTDDuration9197000JPY
Other comprehensive incomeCurrentYTDDuration-20748000JPY
Comprehensive incomePrior1YTDDuration129929000JPY
Comprehensive incomeCurrentYTDDuration172078000JPY
Comprehensive income attributable to owners of the parentPrior1YTDDuration129929000JPY
Comprehensive income attributable to owners of the parentCurrentYTDDuration172078000JPY
Comprehensive income attributable to non controlling interestsPrior1YTDDuration-JPY
Comprehensive income attributable to non controlling interestsCurrentYTDDuration-JPY
Income before income taxesPrior1YTDDuration155197000JPY
Income before income taxesCurrentYTDDuration252399000JPY
Depreciation and amortization ope cfPrior1YTDDuration201810000JPY
Depreciation and amortization ope cfCurrentYTDDuration200147000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2023-11-30pass
balance sheet identityconsolidated 2024-05-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-11-30pass
statement vs summary · net assetsconsolidated 2024-05-31pass
statement vs summary · net income attributable to parentconsolidated 2022-12-01/2023-05-31pass
statement vs summary · net income attributable to parentconsolidated 2023-12-01/2024-05-31pass
statement vs summary · operating cash flowconsolidated 2022-12-01/2023-05-31pass
statement vs summary · operating cash flowconsolidated 2023-12-01/2024-05-31pass
statement vs summary · revenueconsolidated 2022-12-01/2023-05-31pass
statement vs summary · revenueconsolidated 2023-12-01/2024-05-31pass
statement vs summary · total assetsconsolidated 2023-11-30pass
statement vs summary · total assetsconsolidated 2024-05-31pass